Wealthspring Capital LLC Takes $1.10 Million Position in Translational Development Acquisition Corp. (NASDAQ:TDACU)

Wealthspring Capital LLC purchased a new stake in Translational Development Acquisition Corp. (NASDAQ:TDACUFree Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 59,360 shares of the company’s stock, valued at approximately $1,095,000. Translational Development Acquisition comprises 1.8% of Wealthspring Capital LLC’s portfolio, making the stock its 20th biggest position.

Several other institutional investors and hedge funds have also modified their holdings of the business. Calamos Advisors LLC acquired a new position in Translational Development Acquisition during the 4th quarter worth approximately $6,915,000. Wolverine Asset Management LLC acquired a new position in Translational Development Acquisition during the 4th quarter worth approximately $5,716,000. MMCAP International Inc. SPC acquired a new position in Translational Development Acquisition during the 4th quarter worth approximately $6,454,000. Finally, Tuttle Capital Management LLC acquired a new position in Translational Development Acquisition during the 4th quarter worth approximately $461,000.

Translational Development Acquisition Price Performance

NASDAQ:TDACU opened at $10.13 on Wednesday. Translational Development Acquisition Corp. has a twelve month low of $10.00 and a twelve month high of $10.30. The business’s 50 day moving average price is $10.05.

Translational Development Acquisition Company Profile

(Free Report)

Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.

Further Reading

Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACUFree Report).

Institutional Ownership by Quarter for Translational Development Acquisition (NASDAQ:TDACU)

Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.